Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

[1]  Maciej Banach,et al.  The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact , 2022, Diabetes Therapy.

[2]  L. Martínez-Alarcón,et al.  Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity , 2022, bioRxiv.

[3]  G. Muscogiuri,et al.  Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood , 2022, International Journal of Obesity.

[4]  Julio J. Ochoa,et al.  Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review , 2022, Journal of Physiology and Biochemistry.

[5]  X. Terra,et al.  Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome , 2022, Journal of personalized medicine.

[6]  G. Pioggia,et al.  Comprehensive Analysis of the ILCs and Unconventional T Cells in Virus Infection: Profiling and Dynamics Associated with COVID-19 Disease for a Future Monitoring System and Therapeutic Opportunities , 2022, Cells.

[7]  Xu Jia,et al.  Potential Genes Associated with COVID-19 and Comorbidity , 2022, International journal of medical sciences.

[8]  P. Ordunez,et al.  Cardiac Manifestations in Patients with COVID-19: A Scoping Review , 2022, Global heart.

[9]  R. Santos,et al.  Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel , 2021, Frontiers in Cardiovascular Medicine.

[10]  G. Hindricks,et al.  European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis , 2021, European heart journal.

[11]  M. Skonieczna,et al.  Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes , 2021, Scientific reports.

[12]  D. Nuzzo,et al.  The Role of Endothelium in COVID-19 , 2021, International journal of molecular sciences.

[13]  S. Srivastav,et al.  COVID 19 in-hospital mortality, body mass index and obesity related conditions , 2021, Journal of Diabetes and its Complications.

[14]  G. Frühbeck,et al.  FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes , 2021, Cellular & Molecular Immunology.

[15]  C. Clapp,et al.  The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling , 2021, bioRxiv.

[16]  C. Conte,et al.  Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19 , 2021, Diabetes & Metabolism.

[17]  B. Özkan,et al.  Evaluation of predictors of severe‐moderate COVID‐19 infections at children: A review of 292 children , 2021, Journal of medical virology.

[18]  Nan Wang,et al.  Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities , 2021, Theranostics.

[19]  M. Rizzo,et al.  Diabetes and COVID-19: A Tale of 2 Pandemics , 2021, Journal of cardiovascular pharmacology.

[20]  Prince Sebastian,et al.  COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality , 2021, Frontiers in Immunology.

[21]  O. Ziegler,et al.  Obesity and mortality in critically ill COVID-19 patients with respiratory failure , 2021, International Journal of Obesity.

[22]  B. Bonnotte,et al.  Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19? , 2021, International Journal of Obesity.

[23]  C. Zheng,et al.  Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D , 2021, International journal of molecular sciences.

[24]  P. Picone,et al.  Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge , 2021, Journal of clinical medicine.

[25]  Yong Tang,et al.  P2X7 Receptor–Mediated Inflammation in Cardiovascular Disease , 2021, Frontiers in Pharmacology.

[26]  P. Picone,et al.  Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient , 2021, Brain sciences.

[27]  M. Banach,et al.  COVID-19 and cardiovascular complications – preliminary results of the LATE-COVID study , 2021, Archives of medical science : AMS.

[28]  F. Kobeissy,et al.  Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19 , 2021, Frontiers in Medicine.

[29]  R. Santos,et al.  Increased circulating levels of angiotensin-(1–7) in severely ill COVID-19 patients , 2021, ERJ Open Research.

[30]  G. Fabbrocini,et al.  Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19 , 2021, Scientific Reports.

[31]  Lulu Chen,et al.  Obesity is associated with severe COVID-19 but not death: a dose−response meta-analysis , 2021, Epidemiology and Infection.

[32]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[33]  C. Lumeng,et al.  Pathways to Severe COVID‐19 for People with Obesity , 2020, Obesity.

[34]  Pingping Zhang,et al.  Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis , 2020, European Journal of Medical Research.

[35]  P. Zimmet,et al.  Proportion of newly diagnosed diabetes in COVID‐19 patients: A systematic review and meta‐analysis , 2020, Diabetes, obesity & metabolism.

[36]  Junxia Zhang,et al.  Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus , 2020, Journal of Diabetes and its Complications.

[37]  P. Jia,et al.  Impact of obesity on COVID-19 patients , 2020, Journal of Diabetes and its Complications.

[38]  R. Webby,et al.  Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes , 2020, bioRxiv.

[39]  N. Kapoor,et al.  Normal weight obesity and COVID-19 severity: A poorly recognized link , 2020, Diabetes Research and Clinical Practice.

[40]  N. Kapoor,et al.  Newly diagnosed diabetes in COVID-19 patients , 2020, Primary Care Diabetes.

[41]  B. Popkin,et al.  Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[42]  K. Thankappan,et al.  Prevalence of normal weight obesity and its associated cardio-metabolic risk factors – Results from the baseline data of the Kerala Diabetes Prevention Program (KDPP) , 2020, PloS one.

[43]  R. Faria,et al.  The potential involvement of P2X7 receptor in COVID‐19 pathogenesis: A new therapeutic target? , 2020, Scandinavian journal of immunology.

[44]  M. Rizzo,et al.  Gender differences in the battle against COVID‐19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes , 2020, International journal of clinical practice.

[45]  M. van Meurs,et al.  Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue , 2020, Heliyon.

[46]  M. Rudelius,et al.  Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy , 2020, Circulation.

[47]  Hamid Aria,et al.  The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis , 2020, Life Sciences.

[48]  P. Kirchhof,et al.  Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.

[49]  G. Frühbeck,et al.  Obesity and COVID-19: The Two Sides of the Coin , 2020, Obesity Facts.

[50]  F. Greenway,et al.  Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link? , 2020, International Journal of Obesity.

[51]  P. Picone,et al.  Potential neurological effects of severe COVID-19 infection , 2020, Neuroscience Research.

[52]  M. Banach,et al.  Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series? , 2020, Archives of medical science : AMS.

[53]  Bruce Guthrie,et al.  Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study , 2020, The Lancet Global Health.

[54]  E. Nisoli,et al.  COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity , 2020, International Journal of Obesity.

[55]  M. Catanzaro,et al.  Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 , 2020, Signal Transduction and Targeted Therapy.

[56]  S. Mukherjee,et al.  In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs , 2020, Journal of medical virology.

[57]  C. Rochitte,et al.  O Coração e a COVID-19: O que o Cardiologista Precisa Saber , 2020, Arquivos brasileiros de cardiologia.

[58]  D. Gozal,et al.  Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection , 2020, European Respiratory Journal.

[59]  M. Tay,et al.  The trinity of COVID-19: immunity, inflammation and intervention , 2020, Nature Reviews Immunology.

[60]  Tianyuan Wang,et al.  Cytokine storm intervention in the early stages of COVID-19 pneumonia , 2020, Cytokine & Growth Factor Reviews.

[61]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[62]  N. Caplice,et al.  Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019? , 2020, Obesity.

[63]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[64]  M. Rizzo,et al.  COVID-19 and diabetes management: What should be considered? , 2020, Diabetes Research and Clinical Practice.

[65]  M. Rizzo,et al.  Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. , 2020, Metabolic syndrome and related disorders.

[66]  E. Coomes,et al.  Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis , 2020, medRxiv.

[67]  Qiurong Ruan,et al.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.

[68]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[69]  J. González-Martín,et al.  Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. , 2020, The Lancet. Respiratory medicine.

[70]  P. Thall,et al.  Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors. , 2020, The New England journal of medicine.

[71]  J. Ralston,et al.  Toward a broader response to cardiometabolic disease , 2019, Nature Medicine.

[72]  L. Lynch,et al.  Innate Immune Control of Adipose Tissue Homeostasis. , 2019, Trends in immunology.

[73]  C. Shi,et al.  SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes , 2019, Cell Death Discovery.

[74]  Guansong Wang,et al.  Endothelial Cell Inflammation and Barriers Are Regulated by the Rab26-Mediated Balance between β2-AR and TLR4 in Pulmonary Microvessel Endothelial Cells , 2019, Mediators of inflammation.

[75]  T. Yoshikawa.  [Inflammation and oxidative stress]. , 2006, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[76]  T. Cullen,et al.  Global existence of solutions for the relativistic Boltzmann equation on the flat Robertson-Walker space-time for arbitrarily large intial data , 2005, gr-qc/0507035.

[77]  G. Bray,et al.  Obesity , 2008, Annals of Internal Medicine.